Association of type 1 diabetes mellitus and epilepsy in children. A cohort of 10 cases;Association diabète de type 1 et épilepsie chez l'enfant. À propos d'une série de 10 cas

Archives de Pediatrie

Volumn 19, Issue 1, 2012, Pages 9-16

  Caietta, E ^a   Halbert, C ^a   Lepine A ^a,b,c   Khammar, A ^a   Cano, A ^a   Gavaret, M ^a,c   Mancini, J ^a,c   Villeneuve, N ^a,b,c   Chabrol, B ^a,c   Simonin, G ^a   Reynaud, R ^a   Milh, M ^a,b,c  

^a TIMONE HOSPITAL   (France)

^b Hopital Henri Gastaut   (France)

^c Centre d'investigation neurologique pour les adultes   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMATE DECARBOXYLASE ANTIBODY;

ARTICLE; CHILD; CLINICAL ARTICLE; COMORBIDITY; DISEASE ASSOCIATION; EPILEPSY; FOCAL EPILEPSY; FRANCE; GENERALIZED EPILEPSY; GLYCEMIC CONTROL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; ONSET AGE; RETROSPECTIVE STUDY; UNIVERSITY HOSPITAL;

ADOLESCENT; AUTOANTIBODIES; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DIABETES MELLITUS, TYPE 1; DIAGNOSIS, DIFFERENTIAL; EPILEPSY, GENERALIZED; EPILEPSY, TEMPORAL LOBE; FEMALE; GLUTAMATE DECARBOXYLASE; HOSPITALS, UNIVERSITY; HUMANS; INFANT; MALE; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SEX DISTRIBUTION;

EID: 84855204785     PISSN: 0929693X     EISSN: 1769664X     Source Type: Journal    
DOI: 10.1016/j.arcped.2011.10.010     Document Type: Article

References (22)

1. Lévy-Marchal C, Fagot-Campagna A, Daniel M, et al. Surveillance épidémiologique du diabète de l'enfant. Institut national de la santé et de la recherche médicale et Institut national de veille sanitaire 2007. Disponible sur internet (octobre 2011). http://www.invs.sante.fr/publications/2007/diabete_enfant/diabete_enfant.pdf.
2. Charkaluk M.L., Czernichow P., Levy-Marchal C., et al. Incidence data of childhood-onset type 1diabetes in France during 1988-1997: the case for a shift toward younger age at onset. Pediatr Res 2002, 52(8):59-62.
3. Barat P., Valade A., Brosselin P., et al. The growing incidence of type 1diabetes in children: the 17-year French experience in Aquitaine. Diabetes Metab 2008, 34:601-605.
4. Sabbah E., Savola K., Ebeling T., et al. Genetic, autoimmune, and clinical characteristics of childhood- and adult-onset type 1diabetes. Diabetes Care 2000, 23:1326-1332.
5. Jallon P., Picard F. épidémiologies des épilepsies de l'enfant. Med Ther Pediatr 2000, 4:10-15.
6. Luna D., Chiron C., Pajot N., et al. épidémiologie des épilepsies de l'enfant dans le département de l'Oise (France). épidémiologie des épilepsies 1988, 41-53. John Libbey Eurotext, Paris. P. Jallon (Ed.).
7. McCorry D., Nicolson A., Smith D., et al. An association between type 1diabetes and idiopathic generalized epilepsy. Ann Neurol 2006, 59:204-206.
8. Mancardi M., Striano P., Giannattasio A., et al. Type 1diabetes and epilepsy: more than a casual association?. Epilepsia 2010, 2:319-322.
9. Olson J., Olson D., Sandborg C., et al. Type 1diabetes mellitus and epilepsia partialis continua in a 6-year-old boy with elevated anti-GAD65antibodies. Pediatrics 2002, 109:E50.
10. O'Connell M., Harvey A., Mackay M., et al. Does epilepsy occur more frequently in children with type 1diabetes?. J Paediatr Child Health 2008, 44:586-589.
11. Craig M.E., Hattersley A., Donaghue K.C., et al. ISPAD clinical practice consensus guidelines 2009compendium. Definition, epidemiology and classification of diabetes in children and adolescents. Pediatr Diabetes 2009, 10:3-12.
12. Berg A., Berkovic S., Brodie M., et al. Revised terminology and concepts for organization of the epilepsies: report of the commission on classification and terminology. Epilepsia 2010, 51:676-685.
13. Baxter C., Roberts E. The γ-aminobutyric acid-α-ketoglutaric acid transaminase of beef brain. J Biol Chem 1958, 233:1135-1139.
14. Mitoma H., Ishida K., Shizuka-Ikeda M., et al. Dual impairment of GABAA and GABAB-receptor mediated synaptic responses by autoantibodies to glutamic acid decarboxylase. J Neurol Sci 2003, 208:51-56.
15. Kash S., Johnson R., Tecott L., et al. Epilepsy in mice deficient in the 65-kDa isoform of glutamic acid decarboxylase. Neurobiology 1997, 94:14060-14065.
16. Hijazi J., Bedat-Millet A.-L., Hannequin D., et al. Le syndrome de l'homme raide et autres maladies neurologiques associées aux anticorps anti-GAD. Rev Med Int 2010, 31:23-28.
17. Pittock S., Yoshikawa H., Ahlskog E., et al. Glutamic acid decarboxylase auto-immunity with brainstem, extrapyramidal and spinal cord dysfunction. Mayo Clin Proc 2006, 81:1207-1214.
18. Saiz A., Blanco Y., Sabater L., et al. Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association. Brain 2008, 131:2553-2563.
19. Errichiello L., Perruolo G., Pascarella A., et al. Autoantibodies to glutamic acid decarboxylase in focal and generalized epilepsy: a study on 233patients. J Neuroimmunol 2009, 211:120-123.
20. Peltola J., Kulmala P., Isojärvi J., et al. Autoantibodies to glutamic acid decarboxylase in patients with therapy-resistant epilepsy. Neurology 2000, 55:46-50.
21. Giometto B., Nicolao P., Macucci M., et al. Temporal-lobe epilepsy associated with glutamic-acid-decarboxylase autoantibodies. Lancet 1998, 352:457.
22. Huang C., Tsai J., Ou H., et al. Diabetic hyperglycemia is associated with the severity of epileptic seizures in adults. Epilepsy Res 2008, 79:71-77.